COVID-19—from Mucosal Immunology to IBD Patients

0
6
Scientists review the current understanding of intestinal tropism of SARS-CoV-2 infection, its impact on mucosal function and immunology and summarize the effect of immune-suppression in patients with inflammatory bowel disease (IBD) on disease outcome of COVID-19
[Mucosal Immunology]
Weidinger, C., Hegazy, A. N., Glauben, R., & Siegmund, B. (2021). COVID-19—from mucosal immunology to IBD patients. Mucosal Immunology, 1–8. https://doi.org/10.1038/s41385-021-00384-9 Cite
Full Article